Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (76,932)	$ (37,614)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation	159	71
Equity-based compensation	1,002	8
Cantor Commitment Fee	1,600
Amortization of consulting fees	2,954
Change in fair value of convertible debentures	28,180	24,890
Change in fair value of forward purchase agreement collateral derivative	27,378
Change in fair value of warrants	(1,349)
Change in fair value of forward purchase agreement put derivative	1,284
Conversion of accrued interest	593
Contributions in the form of rent payments	225	410
Amortization of right-of-use assets	20
Accretion of operating lease liabilities	(20)
Recognition of prepaid offering costs upon election of fair value option	107
Accretion of interest earned on investment in convertible promissory note		(26)
Other		13
Changes in operating assets and liabilities:
Supplies	(1,762)	(296)
Prepaid expenses, consulting fees, and other current assets	(1,002)	55
Cloud computing arrangements	(1,941)	(1,701)
Reinsurance recoverables	709	88
Accounts payable	(489)	2,247
Accrued and other liabilities	761	197
Policy reserves	(709)	(88)
Net cash used in operating activities	(19,232)	(11,746)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of property and equipment	(108)	(73)
Asset acquisition, net of cash acquired		(63)
Development of internal use software	(1,622)	(9)
Acquisition of convertible promissory note		(50)
Net cash used in investing activities	(1,730)	(195)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from issuance of related party convertible debentures		3,250
Proceeds from issuance of convertible debentures	28,000	7,250
Warrant repurchase	(507)
Senior PIK Notes proceeds	3,458
Reverse recapitalization proceeds	23,226
Forward purchase agreement escrow	(29,135)
Forward purchase agreement proceeds	484
Forward purchase agreement collateral release to Meteora	733
Deferred offering costs	(539)
Related party promissory note	(1,160)
Proceeds received from stockholder subscription receivable		3,750
Net cash provided by financing activities	24,560	14,250
Net increase in cash and cash equivalents	3,598	2,309
Cash and cash equivalents at beginning of period	6,856	8,123
Cash and cash equivalents at end of period	10,454	10,432
NONCASH INVESTING AND FINANCING ACTIVITIES:
Conversion of phantom equity to stock options		$ 54
Conversion of debt	88,382
Conversion of preferred stock	21,854
Accrued internal use software	$ 239